Provincial Biosimilar Drug update

Alberta Biosimilar Initiative
On December 12, 2019, the Alberta government introduced the launch of the Alberta Biosimilar Initiative. This program will require patients using several originator biologic drugs to switch to a biosimilar, and patients using a non-biologic complex drug (NBCD) to switch to its subsequent entry version before July 1, 2020 in order to maintain coverage.

See the following pdf to learn more:


Share on facebook
Share on twitter
Share on pinterest
Share on linkedin

We’re ready to help. With COVID-19 top of mind, we’re committed to keeping you informed. Learn More